These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31994517)
1. [Cerebrolysin peptides as mood stabilizers]. Torshin IY; Gromova OA; Zgoda VG; Tikhonova OV; Malyavskaya SI Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12):69-75. PubMed ID: 31994517 [TBL] [Abstract][Full Text] [Related]
2. [An analysis of the peptide composition of a 'light' peptide fraction of cerebrolysin]. Gromova OA; Torshin IY; Zgoda VG; Tikhonova OV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8):75-83. PubMed ID: 31626174 [TBL] [Abstract][Full Text] [Related]
3. [Neurotrophic peptides of сerebrolysin as a basis for anticonvulsant effect of the drug]. Gromova OA; Kalacheva AG; Grishina TR; Bogacheva TE; Demidov VI; Torshin IY Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):55-62. PubMed ID: 27070474 [TBL] [Abstract][Full Text] [Related]
4. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of neurotrophic and neuroprotective effects of cerebrolysin in cerebral ischemia]. Gromova OA; Torshin IIu; Gogoleva IV Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3 Pt 2):43-50. PubMed ID: 24781241 [TBL] [Abstract][Full Text] [Related]
6. Peptide profiling of Internet-obtained Cerebrolysin using high performance liquid chromatography - electrospray ionization ion trap and ultra high performance liquid chromatography - ion mobility - quadrupole time of flight mass spectrometry. Gevaert B; D'Hondt M; Bracke N; Yao H; Wynendaele E; Vissers JP; De Cecco M; Claereboudt J; De Spiegeleer B Drug Test Anal; 2015 Sep; 7(9):835-42. PubMed ID: 26017115 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and pharmacodynamic synergism between neuropeptides and lithium in the neurotrophic and neuroprotective action of cerebrolysin]. Gromova OA; Torshin IY; Gogoleva IV; Pronin AV; Stelmashuk EV; Isaev NK; Genrikhs EE; Demidov VI; Volkov AY; Khaspekov GL; Alexandrova OP Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):65-72. PubMed ID: 26120985 [TBL] [Abstract][Full Text] [Related]
8. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. Sharma HS; Muresanu DF; Patnaik R; Stan AD; Vacaras V; Perju-Dumbrav L; Alexandru B; Buzoianu A; Opincariu I; Menon PK; Sharma A J Nanosci Nanotechnol; 2011 Sep; 11(9):7549-69. PubMed ID: 22097459 [TBL] [Abstract][Full Text] [Related]
9. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Masliah E; Díez-Tejedor E Drugs Today (Barc); 2012 Apr; 48 Suppl A():3-24. PubMed ID: 22514792 [TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Sharma HS; Zimmermann-Meinzingen S; Johanson CE Ann N Y Acad Sci; 2010 Jun; 1199():125-37. PubMed ID: 20633118 [TBL] [Abstract][Full Text] [Related]
11. Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma. Safarova ER; Shram SI; Grivennikov IA; Myasoedov NF Bull Exp Biol Med; 2002 Apr; 133(4):401-3. PubMed ID: 12124658 [TBL] [Abstract][Full Text] [Related]
13. [Cerebrolysin for acute ischemic stroke]. iganshina LE; Abakumova TR Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635 [TBL] [Abstract][Full Text] [Related]
14. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance. Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195 [TBL] [Abstract][Full Text] [Related]
15. [Anti-inflammatory effects of neurotrophic therapy (a pilot study)]. Malashenkova IK; Krynskiy SA; Hailov NA; Ogurtsov DP; Selezneva ND; Fedorova YB; Ponomareva EV; Kolyhalov IV; Gavrilova SI; Didkovsky NA Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):39-44. PubMed ID: 29927402 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals. Menon PK; Muresanu DF; Sharma A; Mössler H; Sharma HS CNS Neurol Disord Drug Targets; 2012 Feb; 11(1):40-9. PubMed ID: 22229324 [TBL] [Abstract][Full Text] [Related]
19. Comparing the biological activity and composition of Cerebrolysin with other peptide preparations. Seidl LF; Aigner L J Med Life; 2024 Jan; 17(1):24-27. PubMed ID: 38737662 [TBL] [Abstract][Full Text] [Related]
20. A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication. Riley C; Hutter-Paier B; Windisch M; Doppler E; Moessler H; Wronski R J Neural Transm (Vienna); 2006 Jan; 113(1):103-10. PubMed ID: 15843866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]